Skip to footer

DRUG BUREAU CHIEF DEFENDS FDA ON PAYOFFS

  • By Compiled from wire services

| WASHINGTON

The head of the US Food and Drug Administration (FDA) said July 11 that generic drug companies are partly to blame for a payoff scandal in his agency. After 1984 reforms made it easier to put generic drugs on the market, ``many generic drug companies did not hesitate to exert tremendous pressure on FDA drug reviewers,'' FDA Commissioner Frank Young told a House subcommittee.

A year-long federal grand jury probe has so far led to charges of criminal wrongdoing against three FDA employees and three generic drug company executives.

You've read 3 of 3 free articles. Subscribe to continue.
QR Code to DRUG BUREAU CHIEF DEFENDS FDA ON PAYOFFS
Read this article in
https://www.csmonitor.com/1989/0713/afda.html
QR Code to Subscription page
Start your subscription today
https://www.csmonitor.com/subscribe
CSM logo

Why is Christian Science in our name?

Our name is about honesty. The Monitor is owned by The Christian Science Church, and we’ve always been transparent about that.

The Church publishes the Monitor because it sees good journalism as vital to progress in the world. Since 1908, we’ve aimed “to injure no man, but to bless all mankind,” as our founder, Mary Baker Eddy, put it.

Here, you’ll find award-winning journalism not driven by commercial influences – a news organization that takes seriously its mission to uplift the world by seeking solutions and finding reasons for credible hope.

Explore values journalism About us